Ocular Behçet disease and COVID-19. Issue 2 (March 2022)

• Record Type: Journal Article
• Authors: Accorinti, Massimo; Manni, Priscilla; Sampalmieri, Lorenzo; Saturno, Maria Carmela
• Is Part Of: European journal of ophthalmology. Volume 32:Issue 2(2022)
• Page Start: NP148
• Page End: NP149
• Publication Date: 2022-03
• Subjects: ocular Behçet disease -- SARS-CoV-2 -- coronavirus -- uveitis; Ophthalmology -- Periodicals; Eye -- Diseases -- Periodicals; 617.7005
• DOI: 10.1177/11206721221074437
• Languages: English
• ISSNs: 1120-6721

Abstract

Purpose: to study in patients with Behçet disease and ocular involvement (OBD) the presence of SARS-CoV-2 infection and its influence on the course of OBD. Methods: all the patients with OBD living in Lazio, one Italian region, and attending the Uveitis center of the Sapienza University of Rome were included in the study. Results: SARS-CoV-2 infection was found in 12.3% of 54 patients with OBD and in 3.84% of Lazio inhabitants (p = 0.001, OR 3.51), and it was unrelated to the use of immunosuppressive drugs. COVID-19 symptoms in OBD patients were mild, with one patient only requiring hospitalization for interstitial pneumonia. None of the SARS-CoV-2 infected patients presented any uveitis relapses during the infection and in a subsequent median follow-up of 6 months. Conclusion: OBD seems to be a risk factor for developing SARS-CoV-2 infection. Usually this infection has a mild course and does not impact negatively on the course of uveitis.